Yujiro S Hata sold $985k of IDYA
President and CEO at IDEAYA Biosciences, Inc.. 26,338 shares at an average of $37.41, traded Oct 6, 2026, filed Oct 8, 2026.
Score components
- +25RoleCEO
- +25Trade size$985k at market
- 0Share of holdings soldSold 3.7% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-26-000434, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | MOption exercise Common Stock10b5-1 | +26,338 | $4.31 | $114k | 717,033 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stock10b5-1 | -25,538 | $37.39 | $955k | 691,495 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stock10b5-1 | -800 | $38.26 | $31k | 690,695 | 4 d ago |
| Oct 6, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -26,338 | $0.00 | $0 | 23,116 | 4 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.